Literature DB >> 2548865

Quality control parameters and interpretive criteria for in vitro susceptibility tests with the macrolide azithromycin. Collaborative Antimicrobial Susceptibility Testing Group.

A L Barry1, C Thornsberry, T L Gavan.   

Abstract

Quality control parameters for broth microdilution and disk diffusion susceptibility tests were defined and the interpretive criteria for disk diffusion tests reviewed. For interpretation of tests with 15 micrograms azithromycin disks, the following criteria are recommended: greater than or equal to 19 mm for the susceptible category (MIC less than or equal to 2.0 micrograms/ml) and less than or equal to 15 mm for the resistant category (MIC greater than or equal to 8.0 micrograms/ml). Using these criteria, there was 97% overall agreement between broth dilution and disk diffusion tests; Haemophilus influenzae isolates were susceptible to azithromycin by both methods. The quality control strain Staphylococcus aureus ATCC 25923 gave zones of 21 to 26 mm in diameter in a six-laboratory collaborative study. In azithromycin broth microdilution tests the following MIC control limits are recommended: Escherichia coli ATCC 25922, 2.0-8.0 micrograms/ml; Staphylococcus aureus ATCC 29213, 0.25-1.0 micrograms/ml; and Enterococcus faecalis ATCC 29212, 1.0-4.0 micrograms/ml.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2548865     DOI: 10.1007/BF01967477

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  12 in total

1.  Disk diffusion susceptibility testing of two macrolide antimicrobial agents: revised interpretive criteria for erythromycin and preliminary guidelines for roxithromycin (RU 965).

Authors:  R N Jones; A L Barry; P C Fuchs; C Thornsberry
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 5.948

2.  In-vitro activity of erythromycin, roxithromycin and CP 62993 against common paediatric pathogens.

Authors:  S C Aronoff; C Laurent; M R Jacobs
Journal:  J Antimicrob Chemother       Date:  1987-02       Impact factor: 5.790

3.  Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms.

Authors:  J Retsema; A Girard; W Schelkly; M Manousos; M Anderson; G Bright; R Borovoy; L Brennan; R Mason
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

4.  Disk diffusion and disk elution tests with A-56268 and erythromycin.

Authors:  A L Barry; R N Jones; C Thornsberry
Journal:  Eur J Clin Microbiol       Date:  1987-02       Impact factor: 3.267

5.  Susceptibility tests of anaerobic bacteria: statistical and clinical considerations.

Authors:  C M Metzler; R M DeHaan
Journal:  J Infect Dis       Date:  1974-12       Impact factor: 5.226

6.  Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid.

Authors:  A L Barry; T L Gavan; R N Jones; L W Ayers; P C Fuchs; E H Gerlach; C Thornsberry
Journal:  Diagn Microbiol Infect Dis       Date:  1987-05       Impact factor: 2.803

7.  Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae.

Authors:  J H Jorgensen; J S Redding; L A Maher; A W Howell
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

8.  Interpretative criteria for the agar diffusion susceptibility test with azithromycin.

Authors:  A L Barry; R N Jones
Journal:  J Antimicrob Chemother       Date:  1988-11       Impact factor: 5.790

9.  Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution.

Authors:  A E Girard; D Girard; A R English; T D Gootz; C R Cimochowski; J A Faiella; S L Haskell; J A Retsema
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

10.  Variability of clarithromycin and erythromycin susceptibility tests with Haemophilus influenzae in four different broth media and correlation with the standard disk diffusion test.

Authors:  A L Barry; P B Fernandes; J H Jorgensen; C Thornsberry; D J Hardy; R N Jones
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

View more
  5 in total

1.  Biographical Feature: Clyde Thornsberry, Ph.D.

Authors:  Erik Munson
Journal:  J Clin Microbiol       Date:  2015-12-09       Impact factor: 5.948

2.  Influence of the test medium on azithromycin and erythromycin regression statistics.

Authors:  A L Barry; P C Fuchs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-10       Impact factor: 3.267

3.  Design and formulation technique of a novel drug delivery system for azithromycin and its anti-bacterial activity against Staphylococcus aureus.

Authors:  M Joyce Nirmala; Amitava Mukherjee; N Chandrasekaran
Journal:  AAPS PharmSciTech       Date:  2013-06-26       Impact factor: 3.246

Review 4.  Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.

Authors:  D H Peters; H A Friedel; D McTavish
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546

5.  Typhoid fever in young children in Bangladesh: clinical findings, antibiotic susceptibility pattern and immune responses.

Authors:  Farhana Khanam; Md Abu Sayeed; Feroza Kaneez Choudhury; Alaullah Sheikh; Dilruba Ahmed; Doli Goswami; Md Lokman Hossain; Abdullah Brooks; Stephen B Calderwood; Richelle C Charles; Alejandro Cravioto; Edward T Ryan; Firdausi Qadri
Journal:  PLoS Negl Trop Dis       Date:  2015-04-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.